Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one

US9827243B2 · kind B2 · utility

Assignee

• Signal Pharmaceuticals, LLC · US

Inventors

• Matthew Michael Kreilein · Fryeburg, US
• Thomas Lee · Bedminster, US
• Ying Li · Millburn, US
• Jean Xu · Hackettstown, US
• William W. Leong · Westfield, US
• Benjamin M. Cohen · Cranford, US

Key dates

• Filing date: May 10, 2016
• Grant date: Nov 28, 2017
• Expiry date: May 10, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided herein are formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.